Fertility Preservation Toolkit

Thank you for your interest in our toolkits. Please read our Terms of Use carefully as we include information that applies to all our toolkits.

All toolkits are publicly available for individual use without licensing or royalty fees. Such use of toolkits is “single use,” meaning solely for the User’s research, clinical, educational, or other application. User’s email may be added to an email distribution list to receive scientific and updated information about the toolkit(s).

We encourage use of our toolkits. User agrees not to adapt, alter, amend, abridge, modify, condense, make derivative works, or translate toolkits without prior written permission from the Provider. User agrees not to sell or incorporate toolkits into materials that could be sold without prior written consent from the Provider. To inquire about permissions, please email info@a4fp.org.


fertility preservation

Coverage Updates – May 2025

Big win in Georgia! On May 1, 2025, Georgia Governor Brian Kemp signed HB 94 into law, requiring state-regulated commercial health insurance plans in Georgia to cover medically necessary fertility preservation for cancer, sickle cell disease and lupus patients. It is estimated that approximately 1.8 million Georgia residents have individual, small and large group health

Coverage Updates – May 2025 Read More »

AFP Defends Surrogacy

AFP Statement on Pope Francis’s Call for a Global Ban on Surrogacy

In a recent State of the World speech, Pope Francis deemed surrogate motherhood “despicable,” and called for a universal ban on its use. On behalf of the cancer patients and survivors we represent, the Alliance for Fertility Preservation felt compelled to respond to this declaration.  First, let’s be clear — the overwhelming majority of situations involving

AFP Statement on Pope Francis’s Call for a Global Ban on Surrogacy Read More »

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic - blog post image

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic

During this uncertain and unprecedented time, the oncofertility community is working together to provide up-to-date fertility preservation information for patients and providers. We are aware of the recommendations from ASRM’s COVID-19 Task Force which suggests new IVF cycles not be initiated at this time. While this pause in services does not apply to urgent fertility preservation for patients

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic Read More »

New Patient and Expert Videos - blog post image

New Patient and Expert Videos

We are excited to announce the release of new patient and expert videos on the Alliance for Fertility Preservation website! At one of our Stakeholders’ Meetings this spring in Austin, Texas, we had the opportunity to bring together patients, advocates, and healthcare providers from across the state to share ideas and experiences about cancer and

New Patient and Expert Videos Read More »

Major Victory for Cancer Patients as New York Includes Coverage for Fertility Preservation in 2020 Budget - blog post image

Major Victory for Cancer Patients as New York Includes Coverage for Fertility Preservation in 2020 Budget

The New York State Legislature and Governor Andrew Cuomo have just finalized the state’s 2020 budget, which provides for the coverage of all medically necessary fertility preservation procedures by ALL commercial insurers. It also provides for IVF coverage by large group health insurance plans. This extension of coverage marks a tremendous gain for cancer patients,

Major Victory for Cancer Patients as New York Includes Coverage for Fertility Preservation in 2020 Budget Read More »

Treatments for Cancer and Sickle Cell Disease in Boys: Making Sure Their Fertility is Protected - blog post image

Treatments for Cancer and Sickle Cell Disease in Boys: Making Sure Their Fertility is Protected

Recently, scientists discovered that certain treatments for cancer and sickle cell disease destroy the germ cells that eventually go on to develop into sperm in the testes of young boys. This means that the treatment, while important, and potentially lifesaving, may permanently impact their fertility should they want to have children down the road. The study was

Treatments for Cancer and Sickle Cell Disease in Boys: Making Sure Their Fertility is Protected Read More »